Thermo Fisher Scientific (TMO) Free Cash Flow (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Free Cash Flow for 18 consecutive years, with $816.0 million the latest figure, recorded in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $816.0 million, up 126.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 billion (changed 0.36% YoY), and the FY2025 annual result was $6.3 billion, down 13.4% from the prior year.
• Free Cash Flow was $816.0 million for Q1 2026 at Thermo Fisher Scientific, down from $3.0 billion in the prior quarter.
• Over five years, Free Cash Flow peaked at $3.3 billion in Q4 2023 and troughed at $271.0 million in Q2 2023.
• Average Free Cash Flow over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2022.
• Year-over-year, Free Cash Flow plunged 82.65% in 2023 and surged 233.58% in 2024.
• Over 5 years, Free Cash Flow stood at $2.9 billion in 2022, then rose by 12.97% to $3.3 billion in 2023, then declined by 15.31% to $2.8 billion in 2024, then advanced by 6.48% to $3.0 billion in 2025, then sank by 72.73% to $816.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $816.0 million in Q1 2026, $3.0 billion in Q4 2025, and $1.8 billion in Q3 2025.